Abstract
Developmental origins of health and disease (DOHaD) focuses on the earliest stages of human development, and provides a novel paradigm to complement other strategies for lifelong prevention of common chronic health conditions. The 3rd International Congress on DOHaD, held in 2005, retained the most popular features from the first two biannual Congresses, while adding a number of innovations, including increased emphasis on implications of DOHaD for the developing world; programs for trainees and young investigators; and new perspectives, including developmental plasticity, influences of social hierarchies, effects of prematurity, and populations in transition. Emerging areas of science included, first, the controversial role of infant weight gain in predicting adult obesity, diabetes, and cardiovascular disease. Second, in the era of epidemic obesity, paying attention to the over-nourished fetus is as important as investigating the growth retarded one. Third, environmental toxins appear to have abroad range of long-lasting effects on the developing human. Fourth, epigenetic mechanisms could unite several strands of human and animal observations, and explain how genetically identical individuals raised in similar postnatal environments can nonetheless develop widely differing phenotypes. Improving the environment to which an individual is exposed during development may be as important as any other public health effort to enhance population health world wide.
CONGRESS DESCRIPTION
The 3rd International Congress on Developmental Origins of Health and Disease (DOHaD) took place in November 2005 in Toronto, Canada. DOHaD III was the third biannual congress in this area of inquiry, following the 1st and 2nd World Congresses on Fetal Origins of Adult Disease (FOAD) held in Mumbai, India, and Brighton, UK, respectively. The name change from FOAD to DOHaD recognizes the broader scope of developmental cues, extending from the oocyte to the infant and beyond, and the concept that the early life environment has widespread consequences for later health. After the 2nd FOAD Congress, the International Society for DOHaD was formed, with members extending from evolutionary biologists through all branches of the basic and clinical sciences to epidemiologists and public health scientists. The 3rd International Congress was the first to be held under the auspices of the new society.
The 3rd Congress retained the most popular features from the first two Congresses, while adding a number of innovations, including 1) increased emphasis on implications of DOHaD for the developing world; 2) programs for trainees and young investigators; and 3) new perspectives, e.g., evolutionary biology, developmental plasticity, influences of social hierarchies, effects of prematurity, populations in transition, the toxic environment, approaches to data analysis, discussion of controversial areas and policy implications. The content was organized around four domains—exposures, outcomes, mechanisms, and interventions—woven in an integrated fashion throughout the program. The format included both plenary and parallel scientific sessions, with additional special sessions, dedicated poster sessions, and opportunities for interdisciplinary discussion.
Hailing from over 50 countries, 691 delegates attended the Congress. This number represented a substantial increase from FOAD I (502) and FOAD II (531), reflecting the growing interest in the field. Approximately 37% of delegates were from Europe, with 36% from North America, 12% from Asia or Middle East, and the remainder from Australasia, Africa, and Central/South America. Overall 15% were from developing countries. Half were female, and 22% were students. Of the nonstudent delegates, most (62%) worked in academia, and the remainder were split among industry, government, and other occupations.
A core planning committee, comprising the authors of this report, was responsible for overall planning and oversight. The core committee had the able assistance of a local organizing committee as well as an at-large planning committee for developing the scientific program, grading abstracts, and moderating sessions. We received over 500 abstract submissions. At the Congress, delegates presented 100 abstracts orally and more than 300 in poster format.
Delegate evaluations (n = 103) of the Congress were positive. Particularly well-regarded parallel sessions, which consisted of 2-3 invited talks and 4 oral presentations, were those on (exposures) infant feeding and postnatal growth, developmental disruption, social hierarchies; (mechanisms) genetic/epigenetic influences, endocrine mechanisms, programming of nutrition and physical activity, stress/infection, oxidation/endothelium/vasculature; (outcomes) diabetes and metabolic syndrome, cardiovascular disease and risk factors; and (interventions) animal models, clinical and public health interventions. Among the plenary sessions, a particular favorite was a new feature highlighting controversies in the field of DOHaD. Other popular new features were the breakfast workshops, moderated poster sessions for DOHaD New Investigator Award finalists, and meet-the-professor roundtable luncheons. The mean score for overall content of the program was 4.3 on a 1-5 scale with 5 being “excellent.” The most cited concern was inability to attend all sessions of interest, given that 4 to 5 parallel sessions occurred simultaneously.
EMERGING THEMES
In recent years it has become clear that neither genetics alone nor adult lifestyle factors can fully explain rates of common chronic diseases. DOHaD focuses on the earliest stages of human development, and provides a novel paradigm to complement other strategies for lifelong prevention of these conditions (1). It may well be that improving the environment to which an individual is exposed during development is as important as any other public health effort to improve population health world wide. Thus, a better understanding of the DOHaD represents a major area of preventive medicine. We highlight four areas that emerged from DOHaD III.
POSTNATAL INFLUENCES MODULATE INTRAUTERINE PROGRAMMING
At the first plenary session, Honorary Chair David Barker presented recently published results from a Finnish cohort born between the two world wars. In that study, relatively low birth weight combined with poor weight gain until age 2 y followed by increased weight gain during childhood and adolescence predicted development of coronary heart disease as an adult (2). These results are consistent with previously published results from India showing that increasing body mass index through adolescence confers excess risk of impaired glucose tolerance in early adulthood (3).
The particular role of early postnatal growth from birth to 2 y is, however, unresolved. In contrast to the findings from Finland are recent observational studies of term infants and randomized trials of premature infants, summarized by speakers at the Congress. Those studies suggest that accelerated weight gain during infancy, even during the first weeks of life, can result in overweight, insulin resistance, and higher leptin and blood pressure levels one to four decades later (4–6). Some of the discrepancies between studies may result from methodologic considerations or the fact that studies have emanated from different historical eras, but establishing the contemporary situation is of great importance (1).
This issue is critical in developing countries undergoing the epidemiologic transition to chronic diseases (7). In many households, maternal obesity occurs concomitantly with childhood stunting (8,9). In these settings, nutrition programs to achieve increased linear growth must not also cause excess weight gain in childhood (10). Animal studies confirm and extend the epidemiologic observations. In a rat model, maternal energy restriction results in offspring insulin resistance and elevated blood pressure, and these effects are magnified by excess energy intake and weight gain postnatally. However, the prenatally induced effects are not immutable, as administration of leptin at a critical period of hypothalamic development reverses many of the morbid effects (11). Thus, in at least some cases developmental cues may elicit responses that are not programmed in a deterministic way, but are reversible.
Some have used the term “thrifty phenotype” to refer to the observation that babies who are born at lower birth weights (or animal fetuses whose mothers were undernourished), but gain excess weight postnatally, have elevated risks of metabolic and cardiovascular outcomes. More recently, DOHaD scientists have invoked a more all-encompassing term, “predictive adaptive responses,” which posits that the degree of mismatch between early developmental and later influences can predispose to poor health (12,13). This perspective fits well with newer concepts of early origins of obesity, reviewed next.
OBESITY AND ITS CONSEQUENCES ARE EPIDEMIC IN DEVELOPING AS WELL AS DEVELOPED WORLD
Given the worldwide epidemic of obesity, now spreading rapidly from developed to developing countries, the program of DOHaD III contained many sessions related to basic, clinical, and population research into causes and consequences of obesity. While much DOHaD research has focused on “undernutrition” of the fetus (partly determined by maternal diet), there is now an equally important focus on “overnutrition.” Several speakers at the Congress emphasized that while lower birth weight is associated with adverse metabolic outcomes, higher birth weight is associated with higher body mass index in childhood and adulthood, along with an increased risk of obesity and diabetes, (14,15) and animal studies are showing that high-fat or high-energy diets to pregnant mothers can result in similar outcomes (16,17). In addition some studies show that higher birth weight is associated with elevated risks of premenopausal breast cancer, (18) possibly explained by an in utero environment with higher levels of estrogen or leptin (19).
These observations have led to a growing number of human studies and animal experiments examining aspects of maternal energy surfeit, excess gestational weight gain, and gestational diabetes. For example, 3 abstracts presented at the Congress found associations between higher weight gain during pregnancy with offspring obesity in developed world populations (20–22). In an Indian population, female 5-y-old offspring of diabetic mothers, but not diabetic fathers, had increased adiposity and insulin levels (23). As in US populations, the offspring of diabetic mothers were fatter at birth and in childhood (5 y of age), but not at 1 y of age. These findings raise the question of whether a fetal influence (hyperinsulinism) must be combined with a “2nd hit” postnatally to produce the offspring phenotype. In a nonhuman primate model, chronic maternal overfeeding leads to fetal oxidative stress in the liver, resulting in fatty liver and disordered lipid handling (24). In a rat model, higher birth weight from maternal diet-induced obesity leads to mammary tumorigenesis (25).
These findings highlight the adverse effects of the maternal obese and/or diabetic intrauterine environment. Interrupting such effects is crucial in the developed world, where obesity and diabetes are already epidemic, and it is becoming ever more important in developing countries undergoing the nutritional and epidemiologic transition, areas of the world that will witness the largest increases in diabetes in the 21st century (26).
RESEARCH IS EMERGING ON DEVELOPMENTAL DISRUPTION BY ENVIRONMENTAL TOXINS
It is possible that long-term consequences of fetal or infant exposure to very low doses of bisphenol A may occur, due to leaching from polycarbonate plastic. Bisphenol A acts as an estrogen-like compound. In animals, bisphenol A alters cellular signaling, fetal development and adult physiology and reproduction at doses far beneath the currently recommended safe exposure level (27). New scientific evidence on adverse effects of low doses of bisphenol A is required to assess its risk-benefit profile.
Several abstracts addressed other harmful effects of maternal exposures on offspring outcomes. For example, maternal smoking during pregnancy may cause reno-vascular changes (28) and elevated blood pressure.(29) Maternal exposure to endotoxin can result in fetal brain damage in the sheep (30) or altered intestinal growth and barrier function in the rat (31).
Another topic of interest was trans-generational actions of endocrine disruptors on disease development. Fetal exposure to certain endocrine-disrupting compounds, such as the anti-androgenic fungicide vinclozolin, can affect male fertility not only among the offspring, but also in subsequent generations (32). These effects appear to be caused by altered patterns of DNA methylation, which in turn modify transcription and can then induce the development of disease in later life. This is an example of epigenetic inheritance, discussed in the next section.
EPIGENETIC MECHANISMS MAY EXPLAIN OBSERVED PHENOMENA
One of the most exciting emerging themes in the DOHaD field is epigenetics. The notion that a maternal environmental influence such as diet could alter offspring outcomes through epigenetic changes in gene regulation could unite several strands of human and animal observations. Experiments presented at the Congress demonstrated that feeding female Agouti (yellow) mice dietary supplements of vitamin B12, folic acid, betaine and choline just before and throughout their pregnancy can produce graded change in coat color of the offspring, ranging from a yellowish fur from mothers eating a regular diet to brown fur in pups of the supplemented mothers. Furthermore the brown-fur offspring grow up with lower rates of obesity, diabetes and cancer. The epigenetic mechanism associated with this phenomenon involves the switching off the Agouti gene by methyl groups from the supplements (33). Some of these effects appear to be tissue specific and can be induced even in normal rats by maternal dietary manipulation (34). These and similar findings show, in principle, how genetically identical individuals raised in similar postnatal environments, e.g., identical twins, can nonetheless develop widely differing phenotypes.
As noted in the previous section, epigenetic changes in one generation can result in phenotypic changes across many generations. In a broader context, nongenomic trans-generational influences may result from imprinted genes in the embryo and placenta, including epigenetic mechanisms affecting embryonic germ cells, heritable changes to mitochondrial DNA, maternal adaptations to pregnancy and behavioral influences on the newborn, and the range of factors falling under the broad heading of cultural inheritance (35–40). There is now evidence for nongenomic inheritance of many environmentally induced components of risk for later chronic disease (41,42).
OTHER ASPECTS
Several other ramifications of the DOHaD paradigm were in evidence at the Congress. While much attention has focused on the important and common outcomes of obesity, diabetes, and cardiovascular disease, the DOHaD principles apply as well to a range of conditions, including cancer, (25, 43–49) reproductive outcomes, (50,51) mental health and neurologic conditions, (52–57) and respiratory disease, (58–61) as well as body composition. A separate session reflected the primacy of the placenta not only in nutrient transport, but also as an endocrine organ and an important mediator of environmental cues itself (62–66). In addition, the moderator of the parallel session on data analyses enhanced interaction by placing data sets on the DOHaD website ahead of the meeting, so that attendees could analyze these data before listening to how invited discussants handled them.
THE FUTURE
An inherently interdisciplinary field, developmental origins of health and disease has benefited greatly from the biannual Congresses to date, as they bring together under one roof the many scientists who otherwise would not have the opportunity to share their research with those from other fields. From the 1st to the 3rd Congresses, from preconception to adulthood, and from genes to society, there has been an explosion of new information in DOHaD. It is clear that the influence of population sciences on clinical and basic sciences, and vice versa, is catalyzing this growth. The International Society of DOHaD therefore decided to increase the frequency of meetings to annually, with DOHaD IV at the University of Utrecht, Netherlands, in September 2006, and DOHaD V in Perth, Western Australia in November 2007. Details are available at the Society website, www.dohadsoc.org.
References
Gillman MW 2005 Developmental origins of health and disease. N Engl J Med 353: 1848–1850
Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG 2005 Trajectories of growth among children who later have coronary events. N Engl J Med 353: 1802–1809
Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, Biswas SK, Ramji S, Prabhakaran D, Reddy KS 2004 Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350: 865–875
Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, Strom BL 2005 Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 111: 1897 1903
Singhal A, Lucas A 2004 Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 363: 1642–1645
Schack-Nielsen L, Mortensen EL, Michaelsen KF, Renisch JM, Sorensen TI 2005 Life course BMI growth pattern in Danish overweight and obese adults. Pediatr Res 58: 1034–1035
Antonisamy B, Raghupathy P, Fall CH, Geethanjali FS, Priya G, Richard J 2005 The metabolic syndrome and associated lifestyle factors among yourng Indian adults. Pediatr Res 58: 1022
Raphael D, Delisle H 2005 Households with undernourished children and overweight mothers: is this a concern for Haiti?. Pediatr Res 58: 1021
Neufeld L, Leroy J, Rivera J 2005 Maternal overweight concurrent with child stunting in poor families from urban Mexico. Pediatr Res 58: 1021–1022
Corvalan C, Gregory CO, Ramirez-Zea M, Martorell R, Stein AD 2005 Size at birth, infant and childhood growth and adult body siza and composition: a prospective study in a stunted population. Pediatr Res 58: 1022
Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M 2005 Neonatal leptin treatment reverses developmental programming in offspring following maternal undernutrition. Pediatr Res 58: 1128
Gluckman PD, Hanson MA 2004 Living with the past: evolution, development, and patterns of disease. Science 305: 1733–1736
Van den Hove DL, Steinbusch HW, Bruschettini M, Steinbusch H, Prickaerts J, Blanco CE 2005 Prenatal restraint stress and behavior in Fischer 344 rats; the implications of a subsequent exposure to stress. Pediatr Res 58: 1025
Oken E, Gillman MW 2003 Fetal origins of obesity. Obes Res 11: 496–506
Gillman MW, Rifas-Shiman SL, Berkey CS, Field AE, Colditz GA 2003 Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics 111: e221–e226
Armitage JA, Lakasing L, Taylor PD, Balachandran AA, Jensen RI, Dekou V, Ashton N, Nyengaard JR, Poston L 2005 Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol 565: 171–184
Jensen RI, Pombo J, Armitage JA, Poston L, Taylor PD 2005 Offspring of rats fed different high fat diets during pregnancy show significant difference in blood pressure and vascular function at 180 days of age. Pediatr Res 58: 1111
Rich-Edwards JW, Rosner B, Colditz GA, Hibert EN, Michels KB, Wright RJ, Willett WC 2005 Pregnancy outcomes and risk of breast cancer in the mother. Pediatr Res 58: 1010
Webster J, Anand P, Yu B, Khan G, Dettin LE, de Assis S, Shajahan A, Hilakivi-Clarke L 2005 Does high in utero hormonal environment increase breast cancer risk by affecting mammary stem/progenitor cell populations?. Pediatr Res 58: 1010
Schack-Nielsen L, Mortensen EL, Michaelsen KF, Sorensen TI 2005 High maternal pregnancy weight gain is associated with an increased risk of obesity in childhood and adulthood independent of maternal BMI. Pediatr Res 58: 1020
Sharma AM, Cogswell ME, Grummer-Strawn LM 2005 The association between pregnancy weight gain and childhood overweight is modified by mother's pre-pregnancy BMI. Pediatr Res 58: 1038
Oken E, Taveras EM, Kleinman KP, Rich-Edwards JW, Gillman MW 2005 Maternal weight gain during pregnancy and child adiposity at age 3 years. Pediatr Res 58: 1127
Krishnaveni GV, Hill JC, Veena SR, Leary SD, Saperia J, Saroja A, Karat SC, Fall CH 2005 Anthropometry and glucose/insulin concentrations in Indian children – relationships to maternal gestational diabetes. Pediatr Res 58: 1030
McCurdy C, Friedman JE, Grove KL 2005 Chronic maternal overfeeding leads to fetal steatosis and metabolic programming in the non-human primate. Pediatr Res 58: 1039
de Assis S, Hilakivi-Clarke L 2005 High birth weight increases mammary tumorigenesis in rats. Pediatr Res 58: 1047
Wild S, Roglic G, Green A, Sicree R, King H 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053
Welshons WV, Nagel SC, vom Saal FS 2006 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147: S56–S69
Lumb KJ, Triggle C, Zhou X, Pendlebury J, Hasan SU 2005 Cigarette smoke exposure during pregnancy leads to increased systemic arterial blood pressure and attenuated coronary artery relaxation. Pediatr Res 58: 1080
Oken E, Huh SY, Taveras EM, Rich-Edwards JW, Gillman MW 2005 Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes Res 13: 2021–2028
Rees SM, Duncan JR, Cock ML, Suzuki K, Scheerlinck J-P, Hardy R 2005 Chronic, low levels of endotoxin exposure alter fetal brain development and the placenta in the absence of hypoxemia. Pediatr Res 58: 1059
Giannone PJ, Schanbacher BL, Smith CV, Bauer JA, Reber KM 2005 Effects of prenatal lipopolysaccharide exposure on epithelial development and function in newborn rat intestine. Pediatr Res 58: 1080
Anway MD, Skinner MK 2006 Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147: s43–s49
Waterland RA, Jirtle RL 2004 Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63–68
Lillycrop KA, Jackson AA, Hanson MA, Burdge GC 2005 Maternal dietary protein restriction during pregnancy induces altered epigenetic regulation of the glucocorticoid receptor in the liver of the offspring after weaning. Pediatr Res 58: 1031
Jimenez-Chillaron JC, Faucette RR, Reamer C, Barry K, Ruest S, Otis J, Patti ME 2005 Intergenerational effects of fetal programming: potential role of imprinted genes for the inheritance of low birth weight and obesity. Pediatr Res 58: 1038 1039
Miles H, Hofman PL, Cutfield WS 2005 IVF children are taller with increased IGF-I, IGF-II and IGFBP-3 levels suggesting altered genetic imprinting. Pediatr Res 58: 1016
Dziadek M, Ravelich S, Smith G, Patel S, Konycheva G, Krechowec S, Vickers M, Breier BH, Black M 2005 Postnatal loss of Igf2 imprinting in rat offspring born after maternal undernutrition during pregnancy. Pediatr Res 58: 1031
Mu J, Qu D, Adamson SL 2005 A new mouse model of intrauterine growth restriction caused by yolk sac placental dysfunction. Pediatr Res 58: 1063
Simmons RA, Park J, Suponitsky-Kroyer I 2005 Epigenetic regulation of gene expression in Beta-cells of growth retarded rats. Pediatr Res 58: 1100
Lemmen JG, Stavnsgaard H, van der Saag P, Guldberg P, Byskov AG 2005 Fetal target organs of estrogens and hormonal imprinting; use of a transgenic estrogen reporter mouse. Pediatr Res 58: 1045–1046
Gluckman PD, Hanson MA, Spencer HG, Bateson P 2005 Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies. Proc Biol Sci 272: 671–677
Crews D, McLachlan JA 2006 Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147: S4–S10
Zhang Y, Graubard BI, Longnecker MP, Stanczyk FZ, Klebanoff MA, McGlynn KA 2005 Maternal hormone levels and perinatal characteristics: implications for testicular cancer. Pediatr Res 58: 1047
Romundstad PR, Lund Nilsen TI, Vatten L 2005 Birth length, adult height and risk of breast cancer. Pediatr Res 58: 1048
Painter SR, de Rooij SR, Roseboom TJ, Bossuyt PM, Osmond C, Barker DJ, Bleker OP 2005 Breast cancer after prenatal exposure to the Dutch famine. Pediatr Res 58: 1048
Svensson E, Moger TA, Tretli S, Aalen OO, Grotmol T 2005 Frailty modeling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. Pediatr Res 58: 1048
Terry MB, Esserman D, Flom J, James T, Wei Y 2005 Birthweight, growth patterns, and breast cancer risk. Pediatr Res 58: 1048
Troisi R, Douglass C, Hoover RN 2005 A case-control study of early life and growht factors and osteosarcoma. Pediatr Res 58: 1048–1049
Weiderpass E, Romundstad P, Vatten L 2005 Birth size as risk factor for endometrial cancer. Pediatr Res 58: 1049
Collins JW Jr, Simon D, Vyas S, Pierce M, Prachand N, David RJ 2005 Relation of maternal low birth weight to the racial disparity in pregnancy outcome:a population-based study. Pediatr Res 58: 1009
Dunn E, Owen D, Kostaki A, Matthews SG 2005 Prenatal glucocorticoid exposure affects reproductive capacity and adrenocortical function in mature female guinea pig offspring. Pediatr Res 58: 1010–1011
Schlotz W, Phillips DI, Godfrey KM, Jones A 2005 Small size at birth is associated with indicators of increased hyperactivity, reduced attention and reduced effortful control in young children. Pediatr Res 58: 1014
Owen CG, Rudnicka AR, Strachan DP 2005 The effect of breast feeding on vision and myopia in children and young adolescents. Pediatr Res 58: 1014
Lahti J, Raikkonen K, Kajantie E, Pesonen A, Heinonen K, Jarvenpaa A-L, Strandberg T 2005 Small body size at birth in term infants predicts behavioural symptoms of ADHD in preschoolers. Pediatr Res 58: 1014
Bergvall N, Iliadou A, Johansson S, Tuvemo T, Cnattingius S 2005 Effects of fetal growth restriction on risks of low intellectual performers are modified by gestational age. Pediatr Res 58: 1058
Heinonen K, Raikkonen K, Lano K 2005 A Gestational age and body size at birth predict cognitive abilities at 56 months of age among children born at term. Pediatr Res 58: 1059
Pierik FH, van der Pal-de-Bruin KM, Verrips GH, Zybert PA, Lumey LH 2005 Depressive symptoms and self-reported health in middle age after intrauterine undernutrition during the Dutch famine (1944-1945). Pediatr Res 58: 1060
Snibson K, McMurtrie L, Bischof R, Yawno T, Maritzz GS, Cock ML, Hooper S, Harding R 2005 Mild premature birth alters airway structure and function in later life. Pediatr Res 58: 1033
Davies AA, Davey-Smith G, Ben-Schlomo Y, Sivell DA, Litchfield P 2005 Lower birth weight is associated with poorer lung function but not asthma diagnosis in 25839 British Telecom employees. Pediatr Res 58: 1028–1029
Taveras EM, Rifas-Shiman SL, Gold DR, Camargo CA Jr, Oken E, Weiss ST, Gillman MW 2005 Infant weight-for-length as a predictor of wheeze in early childhood. Pediatr Res 58: 1029
Scirica CV, Rifas-Shiman SL, Gillman MW, Weiss ST, Gold DR, Litonjua AA 2005 Prenatal and infant exposure to acetaminophen and the risk for wheeze and eczema during early childhood. Pediatr Res 58: 1037 1038
Jansson N, Pettersson J, Ericsson A, Palmberg I, Powelland TL, Jansson T 2005 Gestational changes in placental function in rats fed a low protein diet. Pediatr Res 58: 1015
Luther JS, Milne JS, Aitken RP, Matsuzaki M, Redmer DA, Reynolds LP, Wallace JM 2005 Preventing maternal growth in the pregnant adolescent dam is associated with altered placental vascularity and modest fetal growth restriction. Pediatr Res 58: 1015
Sandovici I, Angiolini E, Smith P, Smith RJ, Kelsey G, Dean W, Ferguson-Smith AC, Sibley CP, Reik W, Fowden AL, Constancia M 2005 Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Pediatr Res 58: 1015
Rahnama F, Shafiei F, Gluckman PD, Mitchell MD, Lobie PE 2005 Epigenetic regulation of human trophoblastic cell migration. Pediatr Res 58: 1063
Radaelli T, Usmani S, Minium J, Varastepour A, Lepercq P, Catalano P, Hauguel-de Mouzon S 2005 Excess fetal growth and adiposity is negatively correlated with placenta corticotropin-releasing hormone. Pediatr Res 58: 1065
Author information
Authors and Affiliations
Corresponding author
Additional information
The DOHaD Planning Committee is grateful for major financial support from the US National Institutes of Health (grants R13 HD 051239, K24 HL 068041), USAID (grant HRN-A-00-98-00027-00 through the Human Nutrition Institute of the International Life Sciences Institute), Journal of Physiology, the USDA Agricultural Research Service and Baylor College of Medicine. Additional support from Ajinomoto, Arbor Clinical Nutrition Updates, Association of Professors of Gynecology and Obstetrics of Canada, Astellas, Bank of England, British Heart Foundation, CABI, Canadian Institutes of Health Research, Center for Pregnancy and Newborn Research, General Mills, Gynaecologists of Canada, Harvard Medical School, Harvard Pilgrim Health Care Foundation, Lippencott Williams & Wilkins, London Health Sciences Centre, March of Dimes, Mead Johnson, Mt. Sinai Hospital Department of Obstetrics and Gynecology, Nestle, NY University, Ross Pediatrics, The Micronutrient Initiative, Unilever, University of Alberta Perinatal Research Center, University of Toronto Faculty of Medicine, University of Western Ontario Children's Hospital, University of Western Ontario Princess Anne Hospital, US Environmental Protection Agency (grant X3-832770-01-0), and Wellcome Trust.
Rights and permissions
About this article
Cite this article
Gillman, M., Barker, D., Bier, D. et al. Meeting Report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD). Pediatr Res 61, 625–629 (2007). https://doi.org/10.1203/pdr.0b013e3180459fcd
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/pdr.0b013e3180459fcd
This article is cited by
-
Nano-titanium dioxide inhalation exposure during gestation drives redox dysregulation and vascular dysfunction across generations
Particle and Fibre Toxicology (2022)
-
Effects of Maternal Exercise During Pregnancy on Perinatal Growth and Childhood Obesity Outcomes: A Meta-analysis and Meta-regression
Sports Medicine (2021)
-
Association between cesarean delivery types and obesity in preadolescence
International Journal of Obesity (2020)
-
Preterm birth and mortality in adulthood: a systematic review
Journal of Perinatology (2020)
-
Prenatal epigenetics diets play protective roles against environmental pollution
Clinical Epigenetics (2019)